Angiotensin II Type 1 Receptor–Induced Extracellular Signal–Regulated Protein Kinase Activation Is Mediated by Ca 2 (cid:49) /Calmodulin-Dependent Transactivation of Epidermal Growth Factor Receptor Rapid Communication

—The signaling cascade elicited by angiotensin II (Ang II) resembles that characteristic of growth factor stimulation, and recent evidence suggests that G protein–coupled receptors transactivate growth factor receptors to transmit mitogenic effects. In the present study, we report the involvement of epidermal growth factor receptor (EGF-R) in Ang II–induced extracellular signal–regulated kinase (ERK) activation, c- fos gene expression, and DNA synthesis in cardiac fibroblasts. Ang II induced a rapid tyrosine phosphorylation of EGF-R in association with phosphorylation of Shc protein and ERK activation. Specific inhibition of EGF-R function by either a dominant-negative EGF-R mutant or selective tyrphostin AG1478 completely abolished Ang II–induced ERK activation. Induction of c- fos gene expression and DNA synthesis were also abolished by the inhibition of EGF-R function. Calmodulin or tyrosine kinase inhibitors, but not protein kinase C (PKC) inhibitors or downregulation of PKC, completely abolished transactivation of EGF-R by Ang II or the Ca 2 (cid:49) ionophore A23187. Epidermal growth factor (EGF) activity in concentrated supernatant from Ang II–treated cells was not detected, and saturation of culture media with anti-EGF antibody did not affect the Ang II–induced transactivation of EGF-R. Conditioned media in which cells were incubated with Ang II could not induce phosphorylation of EGF-R on recipient cells. Platelet-derived growth factor- (cid:98) receptor was not phosphorylated on Ang II stimulation, and Ang II–induced c- jun gene expression was not affected by tyrphostin AG1478. Our results demonstrated that in cardiac fibroblasts Ang II–induced ERK activation and its mitogenic signals are dominantly mediated by EGF-R transactivated in a Ca 2 (cid:49) /calmodulin-dependent manner and suggested that the effects of Ang II on cardiac fibroblasts should be interpreted in association with the signaling pathways regulating cellular proliferation and/or differentiation by growth factors. ( Circ Res . 1998;82:1338-1348.)

[1]  直彦 大久保.  Angiotensin Type 2 Receptors Are Reexpressed by Cardiac Fibroblasts From Failing Myopathic Hamster Hearts and Inhibit Cell Growth and Fibrillar Collagen Metabolism , 1998 .

[2]  A. Ullrich,et al.  Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.

[3]  B. Margolis,et al.  The 66-kDa Shc Isoform Is a Negative Regulator of the Epidermal Growth Factor-stimulated Mitogen-activated Protein Kinase Pathway* , 1997, The Journal of Biological Chemistry.

[4]  A. Ullrich,et al.  Critical Role of Calcium- dependent Epidermal Growth Factor Receptor Transactivation in PC12 Cell Membrane Depolarization and Bradykinin Signaling* , 1997, The Journal of Biological Chemistry.

[5]  E. Peralta,et al.  The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity , 1997, The EMBO journal.

[6]  J. Pessin,et al.  Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways. , 1997, Endocrinology.

[7]  M. Marrero,et al.  Angiotensin II Stimulates Tyrosine Phosphorylation and Activation of Insulin Receptor Substrate 1 and Protein-tyrosine Phosphatase 1D in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[8]  B. Berk,et al.  Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. , 1997, Circulation research.

[9]  R. Lefkowitz,et al.  Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor , 1997, The Journal of Biological Chemistry.

[10]  Y. Zou,et al.  Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. , 1997, Circulation research.

[11]  S. Kudoh,et al.  Protein Kinase C, but Not Tyrosine Kinases or Ras, Plays a Critical Role in Angiotensin II-induced Activation of Raf-1 Kinase and Extracellular Signal-regulated Protein Kinases in Cardiac Myocytes* , 1996, The Journal of Biological Chemistry.

[12]  Y. Mori,et al.  Down-regulation by cAMP of angiotensin II type 2 receptor gene expression in PC12 cells. , 1996, Hypertension research : official journal of the Japanese Society of Hypertension.

[13]  B. Berk,et al.  Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf. , 1996, Circulation research.

[14]  S. Lev,et al.  A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.

[15]  IsseiKomuro,et al.  Mechanical Stretch Induces Enhanced Expression of Angiotensin II Receptor Subtypes in Neonatal Rat Cardiac Myocytes , 1996 .

[16]  M. Marrero,et al.  The Importance of Tyrosine Phosphorylation in Angiotensin II Signaling. , 1996, Trends in cardiovascular medicine.

[17]  S. Eguchi,et al.  Identification of an Essential Signaling Cascade for Mitogen-activated Protein Kinase Activation by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[18]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[19]  M. Greenberg,et al.  Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Sadoshima,et al.  The heterotrimeric G q protein‐coupled angiotensin II receptor activates p21 ras via the tyrosine kinase‐Shc‐Grb2‐Sos pathway in cardiac myocytes. , 1996, The EMBO journal.

[21]  M. Karin,et al.  Induction of c‐fos expression through JNK‐mediated TCF/Elk‐1 phosphorylation. , 1995, The EMBO journal.

[22]  E. Peles,et al.  Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.

[23]  C. Marshall,et al.  Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[24]  R. Treisman,et al.  The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.

[25]  M. Karin,et al.  Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.

[26]  C. Benjamin,et al.  Convergence of Angiotensin II and Platelet-derived Growth Factor Receptor Signaling Cascades in Vascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[27]  B. Berk,et al.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor , 1995, Nature.

[28]  A. Levitzki,et al.  Tyrosine kinase inhibition: an approach to drug development. , 1995, Science.

[29]  S. Meloche,et al.  Angiotensin II Stimulates Tyrosine Phosphorylation of the Focal Adhesion-associated Protein Paxillin in Aortic Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[30]  L. Mahadevan,et al.  Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.

[31]  C. Slaughter,et al.  ERK phosphorylation potentiates Elk‐1‐mediated ternary complex formation and transactivation. , 1995, The EMBO journal.

[32]  S. Keyse,et al.  Tyrosine kinase inhibition: an approach to drug development. , 1995, Human & experimental toxicology.

[33]  H. Matsubara,et al.  Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. , 1995, The Journal of clinical investigation.

[34]  L. Zon,et al.  Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun , 1994, Nature.

[35]  H. Singer,et al.  Involvement of protein kianse C and Ca2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts. , 1994, The American journal of physiology.

[36]  W. Schorb,et al.  Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. , 1994, The Journal of biological chemistry.

[37]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[38]  H. Matsubara,et al.  Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. , 1994, The Journal of clinical investigation.

[39]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[40]  C. Nobes,et al.  Regulation and function of the Rho subfamily of small GTPases. , 1994, Current opinion in genetics & development.

[41]  R. Treisman.  Ternary complex factors: growth factor regulated transcriptional activators. , 1994, Current opinion in genetics & development.

[42]  M. Shibuya,et al.  Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Inagami,et al.  Angiotensin II Receptor: Molecular Cloning, Functions, and Regulation , 1994 .

[44]  Noel N Kim,et al.  Identification of Functional Angiotensin II Receptors on Rat Cardiac Fibroblasts , 1993, Circulation.

[45]  D. Morrison,et al.  Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase , 1993, Molecular and cellular biology.

[46]  H. Matsubara,et al.  Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. , 1993, Circulation research.

[47]  G. Booz,et al.  Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. , 1993, Circulation research.

[48]  H. Itoh,et al.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. , 1993, The Journal of clinical investigation.

[49]  P. Chambon,et al.  Properties of a purified estradiol-dependent calf uterus tyrosine kinase. , 1993, Biochemistry.

[50]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[51]  A. Ullrich,et al.  Growth factor signaling by receptor tyrosine kinases , 1992, Neuron.

[52]  T. Pawson,et al.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.

[53]  M. Daemen,et al.  Angiotensin II Receptor Blockade After Myocardial Infarction in Rats: Effects on Hemodynamics, Myocardial DNA Synthesis, and Interstitial Collagen Content , 1992, Journal of cardiovascular pharmacology.

[54]  E. Wagner,et al.  Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants , 1992, Molecular and cellular biology.

[55]  G. Booz,et al.  Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. , 1992, Annual review of physiology.

[56]  K. Weber,et al.  Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.

[57]  B. Herman,et al.  Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner , 1990, Molecular and cellular biology.

[58]  M. Karin,et al.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.

[59]  R. Ross,et al.  Methods for studying the platelet-derived growth factor receptor. , 1985, Methods in enzymology.